Skip to main content
Top
Published in: Molecular Cancer 1/2014

Open Access 01-12-2014 | Short communication

The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1

Authors: Kelly J Gauger, Lotfi M Bassa, Elizabeth M Henchey, Josephine Wyman, Jennifer Ser-Dolansky, Akihiko Shimono, Sallie S Schneider

Published in: Molecular Cancer | Issue 1/2014

Login to get access

Abstract

Background

Secreted frizzled-related proteins (SFRPs) are a family of proteins that block the Wnt signaling pathway and loss of Sfrp1 expression is observed in breast cancer. The molecular mechanisms by which obesity contributes to breast tumorigenesis are not well defined, but involve increased inflammation. Mice deficient in Sfrp1 show enhanced mammary gland inflammation in response to diet induced obesity (DIO). Furthermore, mammary glands from Sfrp1 −/− mice exhibit increased Wnt signaling, decreased cell death responses, and excessive hyper branching. The work described here was initiated to investigate whether obesity exacerbates the aforementioned pathways, as they each play a key roles in the development of breast cancer.

Findings

Wnt signaling is significantly affected by DIO and Sfrp1 −/− loss as revealed by analysis of Myc mRNA expression and active β-catenin protein expression. Furthermore, Sfrp1 −/− mice fed a high fat diet (HFD) exhibit an increase in mammary cell proliferation. The death response is also impaired in the mammary gland of Sfrp1 −/− mice fed a normal diet (ND) as well as a HFD. In response to γ-irradiation, mammary glands from Sfrp1−/− mice express significantly less Bax and Bbc3 mRNA, caspase-3 positive cells, and p53 protein. The expression of Wnt4 and Tnfs11 are critical for normal progesterone mediated mammary gland development and in response to obesity, Sfrp1−/− mice express significantly more Wnt4 and Tnfs11 mRNA expression. Evaluation of progesterone receptor (PR) expression showed that DIO increases the number of PR positive cells.

Conclusions

Our data indicate that the expression of Sfrp1 is a critical factor required for maintaining appropriate cellular homeostasis in response to the onset of obesity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE: Waist circumference, waist:hip ratio, and risk of breast cancer in the nurses’ health study. Am J Epidemiol. 1999, 150: 1316-1324. 10.1093/oxfordjournals.aje.a009963.CrossRefPubMed Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE: Waist circumference, waist:hip ratio, and risk of breast cancer in the nurses’ health study. Am J Epidemiol. 1999, 150: 1316-1324. 10.1093/oxfordjournals.aje.a009963.CrossRefPubMed
2.
go back to reference Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.CrossRefPubMed Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.CrossRefPubMed
3.
go back to reference Gauger KJ, Hugh JM, Troester MA, Schneider SS: Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis. Canc Cell Int. 2009, 9: 11-10.1186/1475-2867-9-11.CrossRef Gauger KJ, Hugh JM, Troester MA, Schneider SS: Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis. Canc Cell Int. 2009, 9: 11-10.1186/1475-2867-9-11.CrossRef
4.
go back to reference Gauger KJ, Shimono A, Crisi GM, Schneider SS: Loss of SFRP1 promotes ductal branching in the murine mammary gland. BMC Dev Biol. 2012, 12: 25-10.1186/1471-213X-12-25.PubMedCentralCrossRefPubMed Gauger KJ, Shimono A, Crisi GM, Schneider SS: Loss of SFRP1 promotes ductal branching in the murine mammary gland. BMC Dev Biol. 2012, 12: 25-10.1186/1471-213X-12-25.PubMedCentralCrossRefPubMed
5.
go back to reference Gauger KJ, Schneider SS: The tumor supressor sectrete frizzled related protein 1 regulates p53-mediated apoptosis. Cell Biol Int. 2014, 38: 124-130. 10.1002/cbin.10176.CrossRefPubMed Gauger KJ, Schneider SS: The tumor supressor sectrete frizzled related protein 1 regulates p53-mediated apoptosis. Cell Biol Int. 2014, 38: 124-130. 10.1002/cbin.10176.CrossRefPubMed
6.
go back to reference Gauger KJ, Bassa LM, Henchey EM, Wyman J, Bentley B, Brown M, Shimono A, Schneider SS: Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolim, and enhanced macrophage infiltration. PLoS One. 2013, 8: e78320-10.1371/journal.pone.0078320.PubMedCentralCrossRefPubMed Gauger KJ, Bassa LM, Henchey EM, Wyman J, Bentley B, Brown M, Shimono A, Schneider SS: Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolim, and enhanced macrophage infiltration. PLoS One. 2013, 8: e78320-10.1371/journal.pone.0078320.PubMedCentralCrossRefPubMed
7.
go back to reference Polakis P: Wnt signaling and cancer. Gene Dev. 2000, 14: 1837-1851.PubMed Polakis P: Wnt signaling and cancer. Gene Dev. 2000, 14: 1837-1851.PubMed
8.
go back to reference Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA: Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem. 1999, 274: 16180-16187. 10.1074/jbc.274.23.16180.CrossRefPubMed Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA: Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem. 1999, 274: 16180-16187. 10.1074/jbc.274.23.16180.CrossRefPubMed
9.
go back to reference Satoh W, Gotoh T, Tsunematsu Y, Aizawa S, Shimono A: Sfrp1 and Sfrp2 regulate anteroposterior axis elongation and somite segmentation during mouse embryogenesis. Development (Cambridge, England). 2006, 133: 989-999. 10.1242/dev.02274.CrossRef Satoh W, Gotoh T, Tsunematsu Y, Aizawa S, Shimono A: Sfrp1 and Sfrp2 regulate anteroposterior axis elongation and somite segmentation during mouse embryogenesis. Development (Cambridge, England). 2006, 133: 989-999. 10.1242/dev.02274.CrossRef
10.
go back to reference Mori H, Prestwich TC, Reid MA, Longo KA, Gerin I, Cawthorn WP, Susulic VS, Krishnan V, Greenfield A, Macdougald OA: Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Investig. 2012, 122: 2405-2416. 10.1172/JCI63604.PubMedCentralCrossRefPubMed Mori H, Prestwich TC, Reid MA, Longo KA, Gerin I, Cawthorn WP, Susulic VS, Krishnan V, Greenfield A, Macdougald OA: Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Investig. 2012, 122: 2405-2416. 10.1172/JCI63604.PubMedCentralCrossRefPubMed
11.
go back to reference Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R, Akasaki Y, Shimono A, Walsh K: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science (New York, NY). 2011, 329: 454-457.CrossRef Ouchi N, Higuchi A, Ohashi K, Oshima Y, Gokce N, Shibata R, Akasaki Y, Shimono A, Walsh K: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science (New York, NY). 2011, 329: 454-457.CrossRef
12.
go back to reference Bodine PV, Billiard J, Moran RA, Ponce-de-Leon H, McLarney S, Mangine A, Scrimo MJ, Bhat RA, Stauffer B, Green J, Stein GS, Lian JB, Komm BS: The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem. 2005, 96: 1212-1230. 10.1002/jcb.20599.CrossRefPubMed Bodine PV, Billiard J, Moran RA, Ponce-de-Leon H, McLarney S, Mangine A, Scrimo MJ, Bhat RA, Stauffer B, Green J, Stein GS, Lian JB, Komm BS: The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem. 2005, 96: 1212-1230. 10.1002/jcb.20599.CrossRefPubMed
13.
go back to reference Seol MB, Bong JJ, Baik M: Expression profiles of apoptosis genes in mammary epithelial cells. Mol Cells. 2005, 20: 97-104.PubMed Seol MB, Bong JJ, Baik M: Expression profiles of apoptosis genes in mammary epithelial cells. Mol Cells. 2005, 20: 97-104.PubMed
14.
go back to reference Jiang GX, Liu W, Cui YF, Zhong XY, Tai S, Wang ZD, Shi YG, Li CL, Zhao SY: Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma. Dig Dis Sci. 2010, 55: 2838-2843. 10.1007/s10620-009-1099-3.CrossRefPubMed Jiang GX, Liu W, Cui YF, Zhong XY, Tai S, Wang ZD, Shi YG, Li CL, Zhao SY: Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma. Dig Dis Sci. 2010, 55: 2838-2843. 10.1007/s10620-009-1099-3.CrossRefPubMed
15.
go back to reference Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, Tun HW, Colon-Otero G, Perez EA, Copland JA: Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Canc Therapeut. 2012, 11: 2105-2115. 10.1158/1535-7163.MCT-11-0873.CrossRef Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, Tun HW, Colon-Otero G, Perez EA, Copland JA: Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Canc Therapeut. 2012, 11: 2105-2115. 10.1158/1535-7163.MCT-11-0873.CrossRef
16.
go back to reference Nakano K, Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001, 7: 683-694. 10.1016/S1097-2765(01)00214-3.CrossRefPubMed Nakano K, Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001, 7: 683-694. 10.1016/S1097-2765(01)00214-3.CrossRefPubMed
17.
go back to reference Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y: Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 1997, 16: 2271-2281. 10.1093/emboj/16.9.2271.PubMedCentralCrossRefPubMed Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y: Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 1997, 16: 2271-2281. 10.1093/emboj/16.9.2271.PubMedCentralCrossRefPubMed
18.
go back to reference Sharma SD, Katiyar SK: Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol. 2012, 244: 328-335.CrossRef Sharma SD, Katiyar SK: Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol. 2012, 244: 328-335.CrossRef
19.
go back to reference Ford NA, Dunlap SM, Wheatley KE, Hursting SD: Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator MicroRNA-504. PLoS One. 2013, 8: e68089-10.1371/journal.pone.0068089.PubMedCentralCrossRefPubMed Ford NA, Dunlap SM, Wheatley KE, Hursting SD: Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator MicroRNA-504. PLoS One. 2013, 8: e68089-10.1371/journal.pone.0068089.PubMedCentralCrossRefPubMed
20.
go back to reference Weichhaus M, Broom J, Wahle K, Bermano G: A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer. Int J Oncol. 2012, 41: 745-752.PubMed Weichhaus M, Broom J, Wahle K, Bermano G: A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer. Int J Oncol. 2012, 41: 745-752.PubMed
21.
go back to reference Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P: Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol. 2001, 153: 555-568. 10.1083/jcb.153.3.555.PubMedCentralCrossRefPubMed Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P: Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol. 2001, 153: 555-568. 10.1083/jcb.153.3.555.PubMedCentralCrossRefPubMed
22.
go back to reference Michaelson JS, Leder P: Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene. 2001, 20: 5093-5099. 10.1038/sj.onc.1204586.CrossRefPubMed Michaelson JS, Leder P: Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene. 2001, 20: 5093-5099. 10.1038/sj.onc.1204586.CrossRefPubMed
23.
go back to reference Bradbury JM, Edwards PA, Niemeyer CC, Dale TC: Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol. 1995, 170: 553-563. 10.1006/dbio.1995.1236.CrossRefPubMed Bradbury JM, Edwards PA, Niemeyer CC, Dale TC: Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol. 1995, 170: 553-563. 10.1006/dbio.1995.1236.CrossRefPubMed
24.
go back to reference Faust IM, Johnson PR, Stern JS, Hirsch J: Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol. 1978, 235: E279-E286.PubMed Faust IM, Johnson PR, Stern JS, Hirsch J: Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol. 1978, 235: E279-E286.PubMed
25.
go back to reference Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999, 20: 345-357. 10.1210/edrv.20.3.0367.CrossRefPubMed Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999, 20: 345-357. 10.1210/edrv.20.3.0367.CrossRefPubMed
26.
go back to reference Fernandez-Valdivia R, Mukherjee A, Ying Y, Li J, Paquet M, DeMayo FJ, Lydon JP: The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol. 2009, 328: 127-139. 10.1016/j.ydbio.2009.01.019.CrossRefPubMed Fernandez-Valdivia R, Mukherjee A, Ying Y, Li J, Paquet M, DeMayo FJ, Lydon JP: The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol. 2009, 328: 127-139. 10.1016/j.ydbio.2009.01.019.CrossRefPubMed
27.
go back to reference Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D, Dougall WC: RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 2011, 468: 103-107.CrossRef Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D, Dougall WC: RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 2011, 468: 103-107.CrossRef
28.
go back to reference Hausler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT: Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res. 2004, 19: 1873-1881. 10.1359/JBMR.040807.CrossRefPubMed Hausler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT: Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res. 2004, 19: 1873-1881. 10.1359/JBMR.040807.CrossRefPubMed
29.
go back to reference Fernandez-Valdivia R, Lydon JP: From the ranks of mammary progesterone mediators, RANKL takes the spotlight. Mol Cell Endocrinol. 357: 91-100. Fernandez-Valdivia R, Lydon JP: From the ranks of mammary progesterone mediators, RANKL takes the spotlight. Mol Cell Endocrinol. 357: 91-100.
Metadata
Title
The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1
Authors
Kelly J Gauger
Lotfi M Bassa
Elizabeth M Henchey
Josephine Wyman
Jennifer Ser-Dolansky
Akihiko Shimono
Sallie S Schneider
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2014
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-13-117

Other articles of this Issue 1/2014

Molecular Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine